recall
saveZydus Pharmaceuticals (USA) Inc recall (Cls II)
community read0 votes
clomiPRAMINE Hydrochloride, Capsules, USP, 75 mg, packaged in a) 30-count bottles (NDC 16714-851-01), b) 90-count bottles (NDC 16714-851-02), c) 100 capsules, NDC 16714-851-03 Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India. — Reason: cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit. — Status: Ongoing
view source ↗Data sources
last refreshed 4m ago
Found something off?
same company · ±60 days · 6
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 12, 2025
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 12, 2025
- recallZydus Pharmaceuticals (USA) Inc recall (Cls II)Nov 26, 2025
- approvalENOBY: ENOBY (DENOSUMAB-QBDE) — FDA approvalOct 29, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Oct 22, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls III)Dec 10, 2025
comments(0)
5-min edit window · permanent after that